Previous Article | Next Article ![]()
Infection and Immunity, April 2005, p. 1954-1963, Vol. 73, No. 4
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.4.1954-1963.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Microbial Adhesion Group, Centre for Biomedical Microbiology, BioCentrum-DTU, Technical University of Denmark, Lyngby, Denmark
Received 15 September 2004/ Returned for modification 20 October 2004/ Accepted 22 November 2004
|
|
|---|
|
|
|---|
The TibA protein, a nonorganelle adhesin, was originally found in the classical ETEC serotype O78:H11 strain H10407 (14). The tib locus directs the synthesis of a 104-kDa outer membrane protein, the product of the tibA gene. Although strain H10407 harbors many plasmid-encoded virulence factors, the tib locus is chromosomally encoded (13). Introduction of the tib locus into nonadherent E. coli K-12 hosts directs adhesion to epithelial cell line cells (13). Although cell invasion is not a general trait of ETEC strains, strain H10407 is capable of invading human intestinal epithelial cell line cells (13). It has also been shown that the presence of the tib locus directs not only cell adhesion but also cell invasion with high efficacy (13, 14, 30). TibA was found to be responsible for this capacity.
TibA belongs to the autotransporter protein family. For this group of proteins, which encompasses many virulence factors, the protein itself contains all the information required for traversing the bacterial membrane system and routing to the bacterial cell surface (19, 20). TibA is produced as a precursor consisting of 989 amino acids, which subsequently undergoes extended posttranslational modifications. Initially, it is processed by removal of a 54-amino-acid signal peptide during transit to the periplasm. TibA belongs to an autotransporter subfamily of proteins that contain repetitive amino acid sequence motifs; other members of this subfamily are AIDA, antigen 43 (Ag43), and filamentous hemagglutinin (2, 21, 24). Like these proteins, TibA consists of two domains, a C-terminal translocator domain and an N-terminal passenger domain. The translocator moiety forms a ß-barrel porin in the outer membrane, through which the adhesin moiety gains access to the surface (29). Additional modifications occur since the fully mature TibA adhesin is a glycoprotein. Immediately upstream of the tibA gene is a second gene, tibC, which encodes a 406-residue glycosyltransferase, presumably a heptosyltransferase, that modifies the TibA protein by addition of glycosyl residues (29). Without this modification TibA does not bind to human cells (14, 30).
TibA has been demonstrated to mediate bacterial binding to a range of human cell types that are exemplified by epithelial cell lines such as HEp-2 larynx cells, HuTu80 duodenal cells, HCT8 ileocecal cells, and HCT116 colonic cells (14). This suggests that the molecular motif(s) with which TibA interacts is quite common in the human digestive tract. This versatility is also reflected in the fact that although TibA was originally isolated from H10407, it seems to be widespread among ETEC strains (14).
Several adhesins, such as type 1 fimbriae and curli, have been shown to confer bacterial autoaggregation and/or to enhance biofilm formation on abiotic surfaces in addition to their receptor recognition faculty (16, 43, 46). These phenotypes are recognized as bona fide virulence properties (3, 8, 15). Here we investigated whether the TibA adhesin, in addition to its ability to promote bacterial binding to and invasion of human cells, possesses alternative virulence properties, including autoaggregation of bacterial cells and biofilm formation.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains
|
|
View this table: [in a new window] |
TABLE 2. Plasmids used in this study
|
|
View this table: [in a new window] |
TABLE 3. Primers used in this study
|
(attB) essentially as previously described (11). gfpmut3b* containing a NotI fragment from pOS32 was ligated to the bla-attP-containing NotI fragment of plasmid pLDR11. The ligation mixture was transformed into MS427(pLDR8) cells expressing
Int. Correct chromosomal insertion of gfpmut3b* into an ampicillin-resistant, green fluorescent transformant (OS56) was verified by PCR. E. coli MS427 was labeled with DsRed by transformation with plasmid pAR163, and the resulting strain was designated OS82. The differently labeled fluorescent strains were used as hosts for the expression of TibA via plasmid-encoded genes. DNA manipulations and genetic techniques. Isolation of plasmid DNA was carried out by using a QIAprep Spin Miniprep kit (QIAGEN). Restriction endonucleases were used according to the manufacturer's specifications (Biolabs). Purification of chromosomal DNA from strain H10407 was completed by using a GenomicPrep cell and tissue DNA isolation kit (Amersham Pharmacia Biotech Inc.). All PCRs were performed with the Expand High Fidelity polymerase system (Roche) essentially as previously described (47). The primers used are listed in Table 3. Amplified products were sequenced to ensure fidelity of the PCR (MWG Biotech, Ebersberg, Germany).
Autoaggregation assay. In order to monitor differences in autoaggregation, we used an assay to monitor bacterial settling kinetics over time. Overnight cultures were standardized and mixed vigorously for 15 s prior to the start of the assay. At regular time intervals, a 150-µl sample was taken approximately 0.5 cm from the liquid surface and transferred into a microtiter plate maintained on ice. At the end of the experiment the optical densities at 600 nm were determined by using a microtiter plate reader. When the influence of pH was investigated, the cells were harvested and resuspended in phosphate-buffered saline with different pH values.
Electrophoresis of proteins and detection of glycoproteins. Electrophoresis of whole-cell extracts was performed under denaturing conditions by using a previously described method (47). Cultures that were grown to the exponential phase and were the same optical density were harvested by centrifugation at 10,000 x g for 2 min. Samples were prepared for electrophoresis by resuspending the pelleted bacterial cells in sodium dodecyl sulfate (SDS) sample buffer, followed by boiling for 3 min; aliquots were subjected to SDS-polyacrylamide gel electrophoresis (PAGE). For Western blotting, a polyclonal rabbit antiserum that recognized TibA was used. For glycoprotein detection staining, samples treated for electrophoresis as described above were transferred to nitrocellulose filters as described previously (24). Glycoprotein staining was carried out by using a Roche Molecular Biochemicals digoxigenin glycan detection kit according to the manufacturer's instructions.
Immunofluorescence microscopy. Surface presentation of TibA was assessed by immunofluorescence microscopy by using a polyclonal rabbit antiserum that recognized TibA. A fluorescein isothiocyanate-labeled anti-rabbit serum (Sigma) was used as the secondary antibody. Cell fixation, immunolabeling, and microscopy were carried out as previously described (18).
Biofilm flow chamber experiments. Flow chamber experiments were performed essentially as previously described (7); the major exception was that cells were grown in ABT minimal media (39). Briefly, biofilms were allowed to form on glass surfaces in a multichannel flow system that permitted online monitoring of community structures. Flow cells were inoculated with cultures with a standardized optical density at 600 nm that were pregrown overnight in ABT medium containing chloramphenicol. Glucose was used as the sole carbon source at a concentration of 0.002%.
Microscopy and image analysis. Microscopic observation and image acquisition were performed with a scanning confocal laser microscope (SCLM) (TCS4D; Leica Lasertechnik, GmbH, Heidelberg, Germany) equipped with detectors and filters for monitoring green fluorescent protein (Gfp) and DsRed. Vertical cross sections through the biofilms were generated by using the IMARIS software package (Bitplane AG, Zürich, Switzerland) running on a Silicon Graphics Indigo2 workstation (Silicon Graphics, Mountain View, Calif.). Images were further processed for display by using Photoshop software (Adobe, Mountain View, Calif.).
|
|
|---|
![]() View larger version (27K): [in a new window] |
FIG. 1. (A) Genetic organization of the chromosomally encoded tib locus from E. coli H10407, adapted from the study of Lindenthal and Elsinghorst (29). The locations of PCR primers used for amplification of tibC and tibA are indicated by numbers and arrows. (B) Overview of the plasmid constructs used for expression of TibA (pRMV1) and glycosylated TibA (pRMV1 and pOS38). (C and D) Western blot of E. coli total cell protein (C) and glycoprotein staining of E. coli total cell protein (D) isolated from E. coli MS427 harboring pOS38 and pRMV1 (TibC+ TibA+) (lane i), strain RMV6 harboring pRMV1 (TibA+) (lane ii), and strain RMV3 harboring pACYC184 and pBAD (control) (strain OS60) (lane iii).
|
![]() View larger version (111K): [in a new window] |
FIG. 2. Surface presentation of TibA results in bacterial cell-cell aggregation. Phase-contrast microscopy (left) and immunofluorescence (right) of E. coli vector control strain OS60 (A) and E. coli strain RMV6 harboring pOS38 and pRMV1 (TibC+ TibA+) (B).
|
flu) did not aggregate or settle from liquid suspensions (Fig. 3A). However, cells of strain RMV6 (tibC+ tibA+) were observed to aggregate, and when liquid suspensions of cells were left standing, they flocculated and settled (Fig. 3B). TibA-mediated attachment to and invasion of human cells has been reported to be dependent on glycosylation of the protein; i.e., in the absence of the glycosylation conferred by the tibC heptosyltransferase gene product, TibA does not confer binding to or invasion of human cells (29). To determine if glycosylation played a role in bacterial autoaggregation, we compared cells of strain RMV6 (TibC+ TibA+) and strain RMV3 (TibA+). In both cases the cells aggregated and settled from liquid suspensions (Fig. 3B and C). To obtain a more detailed picture of the aggregation activity of TibA and the role of glycosylation, we compared the autoaggregation profiles of MS427 hosts expressing combinations of the tibA and tibC gene products, viz., RMV12 (TibC+), RMV8 (TibA+), and RMV6 (TibC+ TibA+) (Fig. 4). Strain RMV6 (TibC+ TibA+) was observed to flocculate and settle in a manner similar to RMV8 (TibA+). However, strain RMV12 (TibC+) did not aggregate or settle from liquid suspensions, suggesting that the TibA protein but not the TibC protein is required for bacterial autoaggregation. Taken together, these results indicate that TibA mediates bacterial aggregation and that, in contrast to attachment to human cells, glycosylation of TibA does not play a role in this phenotype.
![]() View larger version (88K): [in a new window] |
FIG. 3. Cell-cell autoaggregation (left) and settling (right) of E. coli vector control strain OS60 (A), E. coli strain RMV6 harboring pOS38 and pRMV1 (TibC+ TibA+) (B), and E. coli strain RMV3 harboring pRMV1(TibA+) (C).
|
![]() View larger version (20K): [in a new window] |
FIG. 4. Settling patterns for liquid suspensions of E. coli MS427 (MG21655 flu) derivative strains harboring (i) pBAD and pACYC184 (control strain OS60), (ii) pOS38 and pRMV1 (TibC+ TibA+) (strain RMV6), (iii) pBAD and pRMV1 (TibA+) (strain RMV8), and (iv) pOS38 and pACYC184 (TibC+) (strain RMV12).
|
Intercellular TibA-TibA interaction is responsible for bacterial autoaggregation. The observed TibA-mediated cell aggregation could have been due to either (i) intercellular TibA-TibA interaction or (ii) intercellular interaction between TibA and some other cell surface component. In order to distinguish between these possibilities, plasmid pRMV1, containing the tibA gene, was transformed into the MS427 derivatives OS56 and OS82 expressing the Gfp and DsRed fluorescent proteins, respectively. The resulting strains were designated OS108 (TibA+ Gfp+) and OS109 (TibA+ DsRed+). When aliquots of OS56 (Gfp+) and OS82 (DsRed+) were mixed, no interaction between these strains was observed, as expected (Fig. 5A). When OS108 cells (TibA+ Gfp+) were mixed with OS82 cells (DsRed+), aggregates composed only of Gfp-tagged OS108 cells were evident, and no interaction between these cells and DsRed-tagged OS82 cells was evident (Fig. 5B). When OS108 (TibA+ Gfp+) and OS109 (TibA+ DsRed+) were mixed, aggregates consisting of both Gfp- and DsRed-tagged cells were produced (Fig. 5C). This suggests that an intercellular TibA-TibA interaction was responsible for the observed cell aggregation. Finally, to determine if glycosylation interfered with or influenced the TibA-TibA interaction, a new construct was prepared. The tibCA fragment from E. coli H10407 was cloned into plasmid pACYC184, resulting in plasmid pRMV4b. Plasmid pRMV4b was transformed into OS56, resulting in strain OS136 (TibCA+ Gfp+). The OS136 cells were mixed with OS109 cells (TibA+ DsRed+). It was clear that mixed aggregates were formed, suggesting that glycosylation is of no consequence in TibA-TibA interactions (Fig. 5D).
![]() View larger version (86K): [in a new window] |
FIG. 5. Intercellular TibA-TibA interactions are responsible for bacterial autoaggregation. SCLM images of E. coli MS427 derivative strains OS56 (Gfp+) and OS82 (DsRed+) (A), OS108 (TibA+ Gfp+) and OS82 (DsRed+) (B), OS109 (TibA+ DsRed+) and OS108 (TibA+ Gfp+) (C), and OS136 (TibCA+ Gfp+) and OS109 (TibA+ DsRed+) (D).
|
TibA-mediated cell aggregation is abolished by concomitant expression of fimbriae.
TibA belongs to the class of short nonorganelle adhesins and has been predicted to protrude about 10 nm from the bacterial surface (21). Consequently, TibA-mediated cell aggregation requires close cell-to-cell contact. We speculated whether expression of type 1 fimbriae, which are
1-µm-long rigid organelles, could physically mask and block the close cell-to-cell contact required for TibA-mediated cell aggregation. To test this hypothesis, we introduced plasmid pPKL4, conferring expression of type 1 fimbriae, into MS427 cells expressing TibA, resulting in strain RMV4. Production of fimbriae was confirmed by agglutination of yeast cells. When cultures of RMV4 (tibA+ fim+), RMV7 (tibA+), RMV10 (fim+), and RMV11 (vector control) were left standing, only RMV7 settled, suggesting that fimbriation blocked TibA-mediated aggregation (Fig. 6A). We previously observed a similar phenomenon in the case of fimbrial elimination of Ag43-mediated cell aggregation (17).
![]() View larger version (97K): [in a new window] |
FIG. 6. (A and B) Cell-cell aggregation imparted by TibA and interference with expression of either type 1 fimbriae (A) or K1 capsule (B). (A) Bacterial settling in static broth mediated by E. coli MS427 harboring pACYC184 and pBR322 (vector control) (tube i), strain RMV11 harboring pRMV1 and pBR322 (TibA+) (tube ii), strain RMV7 harboring pRMV1 and pPKL4 (TibA+ Fim+) (tube iii), or strain RMV4 harboring pPKL4 and pACYC184 (Fim+) (strain RMV10) (tube iv). (B) Bacterial settling in static broth mediated by E. coli MS528 harboring pACYC184 and pBR322 (vector control) (tube i), strain RMV24 harboring pRMV1 and pBR322 (TibA+) (tube ii), strain RMV25 harboring pRMV1 and pKT274 (TibA+ K1+) (tube iii), or strain RMV27 harboring pKT274 and pACYC184 (K1+) (strain RMV26) (tube iv). (C) Western blot of E. coli total cell protein liberated from E. coli MS427 host strains, showing that overexpression of type 1 fimbriae and K1 capsule does not affect surface presentation of TibA. Lane 1, pACYC184 and pBR322 (vector control) (strain RMV11); lane 2, pPKL4 and pACYC184 (Fim+) (strain RMV10); lane 3, pRMV1 and pBR322 (TibA+) (strain RMV7); lane 4, pRMV1 and pPKL4 (TibA+ Fim+) (strain RMV4); lane 5, pACYC184 and pBR322 (vector control) (strain RMV24); lane 6, pKT274 and pACYC184 (K1+) (strain RMV26); lane 7, pRMV1 and pBR322 (TibA+) (strain RMV25); lane 8, pRMV1 and pKT274 (TibA+ K1+) (strain RMV27).
|
To confirm that the surface location of TibA was not affected by type 1 fimbriae or K1 capsule expression, the total cell proteins of strains expressing TibA and TibA plus fimbriae or TibA plus capsule were prepared and examined by SDS-PAGE and Western blotting (Fig. 6C). Clearly, similar quantities of TibA were produced on the surfaces of cells expressing type 1 fimbriae and the K1 capsule, indicating that fimbriae and capsule expression did not affect surface presentation of TibA.
We also examined whether types of capsule other than K1 could mask TibA activity. Introduction of pRMV1 (TibA+) into an isogenic pair of Klebsiella pneumoniae strains, C105 and C105NCV, which differed only in the ability to express K35 capsule, resulted in strains RMV22 and RMV23, respectively. Cells of the noncapsulated strain RMV23 (TibA+) aggregated, while cells of RMV22 (K35+ TibA+) and the vector controls, PKL1019 and PKL1024, did not aggregate (data not shown). Taken together, the results indicate that a capsule indeed blocks the close cell contact required for intercellular TibA-TibA interaction and that this appears to be a general characteristic of capsules.
TibA enhances biofilm formation under continuous-flow growth conditions. Given the cell aggregation characteristics of TibA, we speculated whether this facility could influence biofilm formation. To evaluate the role of TibA in biofilm formation, we compared strains OS108 (TibA+ Gfp+) and OS136 (TibCA+ Gfp+) with the vector control strain OS70 (Gfp+) in flow chamber biofilms. The experimental design enabled us to monitor bacterial distribution within an evolving biofilm under continuous-flow conditions. Furthermore, the spatial distribution of the bacteria could be assessed at the single-cell level due to the combination of fluorescence-tagged cells and scanning confocal laser microscopy. Biofilms were established on glass surfaces in separate flow cells and analyzed. Image analysis of optical sections was performed to examine the distribution and thickness of each established biofilm. The control strain, OS70, produced small, flat microcolonies (Fig. 7A). However, a distinct change in the surface colonization pattern was observed with glycosylated TibA (OS136) and nonglycosylated TibA (OS108) expression (Fig. 7B and C). Initially, loose aggregates were evident in the flow chamber, which developed into thick biofilms by the end of the analysis. No marked difference between the glycosylated and nonglycosylated TibA biofilms was evident.
![]() View larger version (111K): [in a new window] |
FIG. 7. Spatial distribution of biofilm formation for gfp-labeled E. coli MS427 derivative strains. (A) pACYC184 (vector control) (strain OS70). (B) pRMV4b (TibCA+) (strain OS136). (C) pRMV1 (TibA+) (strain RMV3). Biofilm development was monitored by SCLM at 15 h (left images) and 35 h (right images) after inoculation. The images are three-dimensional projections collected for the biofilms and vertical sections (to the right and below for each individual panel) representing the yz plane and the xz plane, respectively, at the positions indicated by the white lines. Scale bars = 50 µm.
|
|
|
|---|
Many E. coli strains are capable of aggregation and employ a range of different systems to this end. A subgroup of type 1 fimbriae, often found in uropathogenic E. coli strains, confer efficient aggregation (43). In enteroaggregative E. coli strains, two thin 2- to 3-nm-wide fimbrial types designated aggregative adherence fimbriae I and II have been identified (9, 36, 37). Expression causes prominent autoaggregation of bacterial cells (38). Also, curli, which are thin surface fibers formed by extracellular precipitation of secreted soluble subunit proteins, confer autoaggregation (16). Likewise, bundle-forming pili mediate autoaggregation (5). Interestingly, many aggregation factors (for example, type 1 fimbriae [46] and curli [50]) also confer biofilm formation.
In contrast to these organelle-type aggregating systems, the self-associating TibA adhesin is anchored directly to the outer membrane. Consequently, TibA-mediated aggregation results in more intimate cell-cell contact than that seen with systems in which the intercellular interactions are based on polymeric structures that reach far from the bacterial surface, like fimbriae. The group of autotransporters that includes TibA, Ag43, and AIDA belongs to a subfamily of E. coli autotransporters that is defined by sequence homology and the presence of repetitive sequence motifs (2, 24, 29). Ag43 was previously shown to be a self-associating molecule that caused bacterial aggregation when it was expressed (10, 17). These shared characteristics prompted us to investigate whether TibA, like Ag43, is a self-recognizing molecule capable of conferring bacterial autoaggregation. Our observations indicate that it does have these properties.
It was originally suggested that the tib locus harbors four genes (29). Here, we demonstrated that only the tibA gene is required for surface display of the TibA protein and that the tibC product is required for glycosylation of TibA. This observation is in line with the fact that TibA belongs to the autotransporter protein family. The other genes present in the tib locus do not seem to be involved in this process but could have regulatory roles, as suggested previously (29). In the present study we showed that TibA expression confers bacterial autoaggregation via intercellular TibA-TibA interaction. TibA belongs to a small, exclusive group of bacterial glycoproteins, and glycosylation of TibA is critical for its binding to human cells (30). Meanwhile, glycosylation is not required for interbacterial TibA-TibA interaction. However, on the other hand, glycosylation does not block this interaction, as demonstrated in this study. The molecular mechanism involved in TibA self recognition is not clear but could involve intermolecular interaction between charged amino acid side chains since pH influenced aggregation.
TibA is a nonorganelle adhesin, and like its distant relatives, Ag43 and AIDA, it probably does not protrude more than
10 nm from the bacterial surface (21). Because of this the biological activity of TibA is masked by more extensive surface structures, like fimbriae and capsules, as demonstrated here. Many ETEC strains are able to express capsule and fimbriae (41, 37). Arguably, the expression of TibA must be coordinated with the expression of more extended surface structures. Future studies on the expressional regulation of tibA might reveal some interesting characteristics.
TibA appears to be a multipurpose protein. In addition to being a bona fide adhesin and invasin (with human cells), it also is an autoaggregator and biofilm enhancer, as demonstrated in this study. At this point it is not clear what these novel TibA-associated phenotypes contribute to the pathogenicity or general environmental behavior of E. coli strains like H10407. Bacteria expressing the TibA aggregating phenotype may exist as tight communities of cells that enjoy all of the benefits of this type of existence. In this respect it is interesting to speculate that TibA-mediated aggregation of E. coli cells may be a tool that aids survival of the organism on route to a mammalian host. Also, aggregation may be a way to assist transfer of bacteria across the gastric acid barrier on the way to the intestines. It is interesting that bacterial aggregation helps passage through the stomach and greatly enhances the infectivity of Vibrio cholerae (52). Furthermore, we demonstrated that TibA expression enhanced biofilm formation very efficiently. The ability to form biofilms is a trait that is closely associated with bacterial persistence and virulence, and many persistent and chronic bacterial infections, including periodontitis, otitis media, biliary tract infections, and endocarditis, are now believed to be linked to the formation of biofilms (8, 12).
A novel and differentiated picture of the TibA autotransporter is emerging. Indeed, this molecule seems to be a highly versatile virulence factor that has multiple potential roles in bacterial pathogenesis, and no less than the following four phenotypes linked to bacterial pathogenicity are associated with TibA: (i) it is a potent adhesin with affinity for a number of different human cells; (ii) it is an efficient invasin that results in bacterial invasion of human cells; (iii) it is capable of mediating bacterial aggregation via intercellular self recognition; and (iv) it is a highly efficient initiator of biofilm formation.
This work was supported by grant 26-02-0183 from the Danish Technical Research Council.
|
|
|---|
attachment site attB of the Escherichia coli chromosome. Plasmid 28:14-24.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»